Digital Trials Digest, our quarterly newsletter
As decentralized trials scale, central rating workflows must keep pace. Here's a clear look at what central rating is, where it fits in trial operations, and why integrated platform delivery is changing the way sponsors manage independent endpoint review.
The conversation at SCOPE 2026 wasn't about what's possible in clinical trials — it was about why it's still so hard to execute. Here's what we heard on the ground.
Discover how simplifying vaccine logistics can make scientific breakthroughs truly global — and why digital innovation is the missing link in equitable access.
The FDA and OHRP have released new draft guidance providing recommendations for making the informed consent process as clear and comprehensive as possible for participants. Here's what you need to know.
Patient-reported outcomes are crucial components of every clinical trial—and they’re stronger and more accurate when captured electronically. Here’s what you need to know about PROs and ePROs.
The rapid expansion of the clinical research market in the Asia-Pacific (APAC) region has opened up significant prospects for carrying out decentralized clinical trials there.
Unstructured data collection from image capture technology can be harnessed to improve the quality of patient-reported data and serve as the bedrock for the training of new algorithms that can help clinicians more accurately diagnose disease.
Enhancing Electronic Patient-Reported Outcomes with digital instruments streamlines and accelerates data collection, making clinical trials more accessible.
This study collected and compared stool ratings from caregivers (Group A), central raters (Group B), and pediatric gastroenterologists (Group C) to discover whether the level of stool consistency of a given photo is more prone to inter-rater variability. The study's results evidence inter-rater variability that is different across Bristol Stool Scale (BSS), which motivates research into standardized training or automated scoring, with a special emphasis on BSS.
Moving into 2022, decentralized models, propelled by breakthroughs in digital technology, will continue to reshape the industry, improving trial outcomes.